116 related articles for article (PubMed ID: 2940092)
21. Evaluation of menogaril in renal cell carcinoma. A Southwest Oncology Group phase II study (8504).
Stephens RL; Goodman P; Crawford ED; Spicer CF; Lowe BA; Ahmann FR; Chapman R; Natale RB
Invest New Drugs; 1990; 8 Suppl 1():S69-71. PubMed ID: 2143177
[TBL] [Abstract][Full Text] [Related]
22. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
Wadler S; Fuks JZ; Wiernik PH
J Clin Pharmacol; 1986; 26(7):491-509. PubMed ID: 2944917
[TBL] [Abstract][Full Text] [Related]
23. Phase II trial of menogaril in advanced colorectal cancer.
Holdener EE; ten Bokkel Huinink WW; Decoster G; Ludwig C; Renard G; Pinedo HM
Invest New Drugs; 1988 Sep; 6(3):227-30. PubMed ID: 2973448
[TBL] [Abstract][Full Text] [Related]
24. Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive days.
Dodion P; de Valeriola D; Crespeigne N; Peeters B; Wery F; van Berchem C; Piccart M; Tueni E; Joggi J; Kenis Y
Eur J Cancer Clin Oncol; 1988 Jun; 24(6):1019-26. PubMed ID: 2970391
[TBL] [Abstract][Full Text] [Related]
25. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
Young CW; Raymond V
Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
[No Abstract] [Full Text] [Related]
26. Phase I clinical trial of oral menogaril administered on three consecutive days.
Dodion P; de Valeriola D; Crespeigne N; Peeters B; Wery F; van Berchem C; Joggi J; Kenis Y
Acta Oncol; 1988; 27(5):517-20. PubMed ID: 2974291
[TBL] [Abstract][Full Text] [Related]
27. Menogaril in the treatment of malignant mesothelioma: a phase II study.
Hudis CA; Kelsen DP
Invest New Drugs; 1992 Jul; 10(2):103-6. PubMed ID: 1386842
[TBL] [Abstract][Full Text] [Related]
28. Phase I study of oral menogaril administered on a once weekly schedule.
Stewart DJ; Verma S; Maroun JA; Robillard L; Earhart RH
Invest New Drugs; 1990 Feb; 8(1):43-52. PubMed ID: 2140564
[TBL] [Abstract][Full Text] [Related]
29. Human pharmacokinetics, excretion, and metabolism of the anthracycline antibiotic menogaril (7-OMEN, NSC 269148) and their correlation with clinical toxicities.
Ratain MJ; Schilsky RL
Cancer Res; 1986 Sep; 46(9):4874. PubMed ID: 2942243
[No Abstract] [Full Text] [Related]
30. Doxorubicin compared with related compounds in a nude mouse model for human ovarian cancer.
Boven E; Schlüper HM; Erkelens CA; Pinedo HM
Eur J Cancer; 1990; 26(9):983-6. PubMed ID: 2149026
[TBL] [Abstract][Full Text] [Related]
31. Phase I trial of menogaril administered as an intermittent daily infusion for 5 days.
Sigman LM; Van Echo DA; Egorin MJ; Whitacre MY; Aisner J
Cancer Treat Rep; 1986 Jun; 70(6):721-5. PubMed ID: 2942244
[TBL] [Abstract][Full Text] [Related]
32. Synergistic combination of menogarol and melphalan and other two drug combinations.
Bhuyan BK; Adams EG; Johnson M; Crampton SL
Invest New Drugs; 1985; 3(3):233-44. PubMed ID: 2933360
[TBL] [Abstract][Full Text] [Related]
33. Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study.
Eisenhauer EA; Pritchard KI; Perrault DJ; Verma S; Pater JL
Invest New Drugs; 1990 Aug; 8(3):283-7. PubMed ID: 2148741
[TBL] [Abstract][Full Text] [Related]
34. Phase II trial of menogaril in patients with advanced colorectal carcinoma: an Illinois Cancer Council trial.
Locker GY; Kilton L; Hoeltgen T; Knop RH; Benson AB; Chernicoff D; Barrett J; Blough R; Johnson C
Cancer Treat Rep; 1987 Sep; 71(9):871-2. PubMed ID: 2957053
[No Abstract] [Full Text] [Related]
35. The biochemical pharmacology of nogalamycin and its derivatives.
Li LH; Krueger WC
Pharmacol Ther; 1991; 51(2):239-55. PubMed ID: 1838416
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of menogaril in advanced malignant melanoma. An EORTC trial.
Gundersen S; Monfardini S; Renard G; Van Glabbeke M; Pinedo H
Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1707-8. PubMed ID: 2962875
[No Abstract] [Full Text] [Related]
37. [Antitumor spectrum of TUT-7 on rat ascitic hepatoma].
Satoh H; Taguchi H; Yahagi S
Gan To Kagaku Ryoho; 1990 Feb; 17(2):287-91. PubMed ID: 2137321
[TBL] [Abstract][Full Text] [Related]
38. Negative phase II trial of menogaril in advanced squamous, adeno- and large cell carcinoma of the lung.
Joss RA; Monfardini S; Hansen M; Dombernowsky P; Renard J; Pinedo HM
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):263-5. PubMed ID: 2833403
[No Abstract] [Full Text] [Related]
39. Phase II study of i.v. menogaril in patients with malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group Study.
McCulloch PB; Eisenhauer EA; Shibata HR; Young VP
Cancer Treat Rep; 1987; 71(7-8):771-2. PubMed ID: 2955887
[No Abstract] [Full Text] [Related]
40. Phase I study of weekly intravenous administration of menogaril to adults with solid tumors.
Stewart DJ; Maroun JA; Verma S; Perrault D; Earhart RH
Am J Clin Oncol; 1989 Dec; 12(6):511-8. PubMed ID: 2531540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
